Latest Market Share News

Page 28 of 71
Wesfarmers Limited reported a 14.4% rise in net profit for FY2025, driven by strong retail performances and strategic portfolio moves. The company also announced a fully-franked final dividend and a significant capital management distribution, signaling confidence amid economic headwinds.
Logan Eniac
Logan Eniac
28 Aug 2025
MotorCycle Holdings Limited has delivered a standout FY2025 performance, posting record revenue and profit while slashing debt and expanding its market footprint. The company’s strategic moves into off-highway vehicles and digital channels signal a bold growth trajectory for FY2026.
Logan Eniac
Logan Eniac
27 Aug 2025
NextEd Group reported a 13.9% revenue decline in FY25, yet maintained resilient EBITDA and strengthened its cash position, signaling a strategic reset underway to capture future growth.
Victor Sage
Victor Sage
27 Aug 2025
Thorney Opportunities Ltd posted a sharp 76% decline in profit after tax for FY2025 yet declared a higher fully franked final dividend and reported growth in net tangible assets per share.
Claire Turing
Claire Turing
27 Aug 2025
Cyclopharm Limited reports a 26% revenue jump to $15.42 million in H1 2025, driven by rapid U.S. expansion and extended patent protections for its Technegas® lung imaging technology.
Ada Torres
Ada Torres
27 Aug 2025
Nova Eye Medical has reported a record A$29.3 million in FY25 revenue, driven by sustained US growth and operational improvements, setting the stage for breakeven EBITDA in the first half of FY26.
Ada Torres
Ada Torres
27 Aug 2025
Compumedics has reported record-breaking sales orders and revenues for FY25, driven by strong US market growth and SaaS adoption, setting the stage for an ambitious FY26 expansion.
Ada Torres
Ada Torres
27 Aug 2025
L1 Long Short Fund Limited reported a net profit after tax of $99.52 million for FY2025, down 42% year-on-year, yet continues its steady dividend growth with a fully franked final dividend of 6.5 cents per share.
Claire Turing
Claire Turing
27 Aug 2025
Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.
Ada Torres
Ada Torres
27 Aug 2025
Mach7 Technologies reported a robust FY25 with 16% revenue growth and a strategic pivot towards customer-centric innovation, underpinned by leadership changes and a strong financial position.
Victor Sage
Victor Sage
27 Aug 2025
COG Financial Services reported a slight dip in net profit after tax but saw strong growth in its Novated Leasing segment, alongside strategic acquisitions and a steady dividend.
Claire Turing
Claire Turing
27 Aug 2025
SciDev Limited reported a 5% revenue decline in FY25 but secured major contracts and reaffirmed strong growth guidance for FY26. Key proprietary technologies like CatChek™ and PFAS treatment are driving expansion.
Victor Sage
Victor Sage
27 Aug 2025